BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12688328)

  • 1. Concurrent mediastinal B cell lymphoma and chronic myeloid leukemia with an unusually favorable response to chemotherapy.
    Au WY; Ma SK; Wan TS; Wang EP; Lau TC; Kwong YL
    Leuk Lymphoma; 2003 Mar; 44(3):535-8. PubMed ID: 12688328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous occurrence of chronic myelogenous leukemia and non-Hodgkin lymphoma at diagnosis.
    Acar H; Ecirli S; Gündoğan F; Bulay O; Acar A
    Cancer Genet Cytogenet; 1999 Jan; 108(2):171-4. PubMed ID: 9973949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients.
    Zinzani PL; Bendandi M; Frezza G; Gherlinzoni F; Merla E; Salvucci M; Magagnoli M; Babini L; Tura S
    Leuk Lymphoma; 1996 Apr; 21(3-4):311-6. PubMed ID: 8726412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia.
    Buño I; Wyatt WA; Zinsmeister AR; Dietz-Band J; Silver RT; Dewald GW
    Blood; 1998 Oct; 92(7):2315-21. PubMed ID: 9746769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.
    Luatti S; Baldazzi C; Marzocchi G; Ameli G; Bochicchio MT; Soverini S; Castagnetti F; Tiribelli M; Gugliotta G; Martinelli G; Baccarani M; Cavo M; Rosti G; Testoni N
    Oncotarget; 2017 May; 8(18):29906-29913. PubMed ID: 28404889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of chronic myelogenous leukemia in a patient with primary thrombocythemia and absence of BCR/ABL rearrangement.
    Cesar JM; Cabello P; Ferro T; Navarro JL
    Cancer Genet Cytogenet; 2006 May; 167(1):74-7. PubMed ID: 16682291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myeloid leukemia as a secondary malignancy after ALK-positive anaplastic large cell lymphoma.
    Alsop S; Sanger WG; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2007 Oct; 38(10):1576-80. PubMed ID: 17889677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
    Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
    Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic myeloid leukemia associated with B-cell chronic lymphocytic leukemia: evidence of two separate clones as shown by combined cell-sorting and fluorescence in situ hybridisation.
    Mansat-De Mas V; Rigal-Huguet F; Cassar G; Kuhlein E; Laurent G; Dastugue N
    Leuk Lymphoma; 2003 May; 44(5):867-9. PubMed ID: 12802927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring of the therapeutic response of interferon to chronic myeloid leukemia by duel-color fluorescence in situ hybridization].
    Song YQ; Li W; Kong LH; Wang GJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):38-40. PubMed ID: 12667287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.
    Schoch C; Schnittger S; Bursch S; Gerstner D; Hochhaus A; Berger U; Hehlmann R; Hiddemann W; Haferlach T
    Leukemia; 2002 Jan; 16(1):53-9. PubMed ID: 11840263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid leukemia.
    Landstrom AP; Ketterling RP; Knudson RA; Tefferi A
    Leuk Lymphoma; 2006 Oct; 47(10):2055-61. PubMed ID: 17071476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary mediastinal B-cell lymphoma with sclerosis: report of 11 cases treated with intensified-CHOP plus radiotherapy.
    Siracusano L; Balzarotti M; Magagnoli M; Castagna L; Rahal D; Santoro A
    Am J Hematol; 2005 Apr; 78(4):312-3. PubMed ID: 15795908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing between proliferating nodal lymphoid blasts in chronic myelogenous leukemia and non-Hodgkin lymphoma: report of three cases and detection of a bcr/abl fusion signal by single-cell analysis.
    Yashima-Abo A; Satoh T; Abo T; Aoki Y; Kowata S; Ito S; Ishida Y; Fujiwara H; Maesawa C; Masuda T
    Pathol Int; 2005 May; 55(5):273-9. PubMed ID: 15871725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Philadelphia negative BCR-ABL positive chronic myeloid leukemia mimicking juvenile chronic myeloid leukemia in a 2-year-old child.
    Mahon FX; Labouyrie E; Aurich-Costa J; Dastugue N; Micheau M; Bady C; Perel Y; Bilhou-Nabera C; Reiffers J; Bernard P
    Leuk Lymphoma; 1997 Aug; 26(5-6):615-9. PubMed ID: 9389369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of minimal residual disease in patients with chronic myeloid leukaemia on IFN-alpha 2b therapy using conventional cytogenetics and fluorescence in situ hybridization.
    Talwar R; Choudhry VP; Jobanputra V; Kucheria K
    Natl Med J India; 2002; 15(4):195-8. PubMed ID: 12296472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
    Wu B; Zhou S; Song L; Liu X
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.